About us

Founded in 2003, Regen Lab has become a global reference thanks to its commitment to innovation, quality, and the effectiveness of its therapeutic solutions.

Patients treated

Countries worldwide

Published studies

Research projetcs

Regen Lab SA is a leader in autologous regenerative medicine. Based in Le Mont-sur-Lausanne, Switzerland, we specialize in preparing Platelet-Rich Plasma (PRP) from the patient’s blood.

Our expertise also extends to advanced cell therapy. This includes combined treatments like PRP with hyaluronic acid.

Regen Lab's patented technologies are now utilized in over 160 countries

In 2009, Regen Lab SA reached a major milestone by opening a state-of-the-art GMP facility. As a result, this achievement firmly positioned us as leaders in high-quality medical device production.

Moreover, Regen Lab’s patented technologies are now utilized in over 160 countries. To date, they have successfully treated more than 2 million patients across various fields, including musculoskeletal disorders, dermatology, wound care, and intimate health.

Additionally, we take pride in our pioneering use of a thixotropic gel for precise blood component separation. This innovation not only ensures our cell therapy products are standardized but also guarantees their reproducibility. Finally, Regen Lab SA is ISO 13485 certified, with all products meeting stringent CE standards.

Our Mission

We are devoted to advancing the frontier of regenerative medicine by delivering state-of-the-art medical devices designed to enhance patient outcomes and elevate quality of life.

Our Facilities

GMP-certified facility in Le Mont-sur-Lausanne epitomizes excellence in medical device manufacturing, upholding the highest standards of safety and efficacy.

Global Presence

With a robust presence in over 90 countries, Regen Lab SA is dedicated to expanding its reach, providing innovative regenerative therapies to millions of patients around the globe.

Patents Portfolio

As a leader in the PRP and HA regenerative field, Regen Lab SA has consistently prioritized innovation since 2004. Consequently, we have invested significant resources to develop pioneering and diverse products. These innovations collectively form a comprehensive set of tools and technologies designed for the medical community.

Furthermore, innovation remains a core pillar of our company. Notably, our team includes over 50 in-house scientists, supported by a unique network of renowned medical doctors. Together, they play a crucial role in advancing Regen Lab’s Research & Development efforts.

0

Active Patents

Since 2003, Regen Lab SA has been committed to the development of a unique expertise for the design and manufa​cturing of high-quality medical devices, intended for cells therapies.

Copyright © 2025 All rights reserved.

About Us

Since 2003, Regen Lab SA has specialized in designing and manufacturing high-quality medical devices for cell therapies and the preparation of autologous platelet-rich plasma (PRP) from the patient's own blood for bedside procedures.

Milestones

2003 - Foundation
2010 - RegenKit first approval in bone graft
2013 - A new state-of-theart laboratory in Lausanne
2014 - Cellular Matrix first approval
2015 - Launch of Cellular Matrix in Europe

Vision

Founded in 2003, Regen Lab has become a global reference thanks to its commitment to innovation, quality, and the effectiveness of its therapeutic solutions. Here’s how we have transformed the medical landscape over the past two decades.

RegenPRP™

RegenPRP™ is a medical treatment that uses platelet-rich plasma from the patient's own blood to enhance and tissue regeneration.

RegenPRP™ - HA

RegenPRP™ - HA combination is an innovative treatment combining platelet-rich plasma (PRP) and hyaluronic acid to improve tissue regeneration and healing.

RegenPRP™ - ATS

RegenPRP™ combined with ATS (Autologous Thrombin Serum) is an advanced approach to tissue regeneration that uses autologous thrombin-enriched platelet-rich plasma (PRP) to maximise healing effects.

RegenExtracell®

RegenExtracell is an innovative tissue regeneration treatment using an extracellular matrix enriched with platelet-rich plasma (PRP).

Hyaluronic Acid

Coming Soon

Regulatory

Manufacturers of medical devices based outside the EU must designate an Authorized Representative (EC-REP) established within the EU in order to meet the CE requirements for placing medical devices on the EU market.

Quality Management

Regen Lab Quality System Management ensures the consistency of our products quality in total GMP compliance.

Our production facility rooms atmosphere is monitored to satisfy non-pyrogenic medical devices manufacturing.

Patents

As a leader in the PRP&HA regenerative field and as an innovation-driven company, Regen Lab SA has devoted important resources since 2004 to put on the market pioneering and diversified products constituting a complete set of tools/technologies for the medical community.